Epidemiologisk evidens for risiko for teratogenicitet efter eksponering for ACE- hæmmere i 1. trimester af graviditeten har ikke været konklusive; en lille risikostigning kan dog ikke udelukkes.
Epidemiological evidence regarding the risk of teratogenicity following exposure to ACE inhibitors during the first trimester of pregnancy has not been conclusive; however a small increase in risk 29 cannot be excluded.